Integrating new technology into blood plasma fractionation
Immune serum globulin is in high demand, and that demand will only increase. Yet despite product shortages, the complexities involved in creating new manufacturing processes discourage change. The benefits--increased yield, reduced costs, new technologies and faster throughput--now make identifying...
Gespeichert in:
| Veröffentlicht in: | Biopharm 2002-09, Vol.15 (9), p.16 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 9 |
| container_start_page | 16 |
| container_title | Biopharm |
| container_volume | 15 |
| creator | Curling, John |
| description | Immune serum globulin is in high demand, and that demand will only increase. Yet despite product shortages, the complexities involved in creating new manufacturing processes discourage change. The benefits--increased yield, reduced costs, new technologies and faster throughput--now make identifying the best place in the processing stream to make manufacturing changes a rewarding endeavor. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_195752139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>187559411</sourcerecordid><originalsourceid>FETCH-proquest_reports_1957521393</originalsourceid><addsrcrecordid>eNqNiksOwiAUAInRxPq5Ax6ApJRSi1uj0b0Ldw1WijXIQ3jGeHs18QBuZmYxA5JxJRTjdVUMPy3LgvGqOo7JJKVrnvNaqDIjq71HY6PG3lvqzZOiaS8eHNgX7T0CPTmAMw1Op5umXdQt9uD1FzMy6rRLZv7zlCy2m8N6x0KE-8MkbKIJEDE1XMmlLLhQ4p_nDTpXN90</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195752139</pqid></control><display><type>article</type><title>Integrating new technology into blood plasma fractionation</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Curling, John</creator><creatorcontrib>Curling, John</creatorcontrib><description>Immune serum globulin is in high demand, and that demand will only increase. Yet despite product shortages, the complexities involved in creating new manufacturing processes discourage change. The benefits--increased yield, reduced costs, new technologies and faster throughput--now make identifying the best place in the processing stream to make manufacturing changes a rewarding endeavor.</description><identifier>ISSN: 1542-166X</identifier><identifier>EISSN: 1939-1862</identifier><language>eng</language><publisher>Cleveland: MultiMedia Healthcare Inc</publisher><subject>Biotechnology industry ; Changes ; Chromatography ; FDA approval ; Fractionation ; Licenses ; Manufacturing ; Plasma ; Polyethylene glycol ; Processes ; Product safety ; Proteins</subject><ispartof>Biopharm, 2002-09, Vol.15 (9), p.16</ispartof><rights>Copyright Advanstar Communications, Inc. Sep 2002</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,780,784,791</link.rule.ids></links><search><creatorcontrib>Curling, John</creatorcontrib><title>Integrating new technology into blood plasma fractionation</title><title>Biopharm</title><description>Immune serum globulin is in high demand, and that demand will only increase. Yet despite product shortages, the complexities involved in creating new manufacturing processes discourage change. The benefits--increased yield, reduced costs, new technologies and faster throughput--now make identifying the best place in the processing stream to make manufacturing changes a rewarding endeavor.</description><subject>Biotechnology industry</subject><subject>Changes</subject><subject>Chromatography</subject><subject>FDA approval</subject><subject>Fractionation</subject><subject>Licenses</subject><subject>Manufacturing</subject><subject>Plasma</subject><subject>Polyethylene glycol</subject><subject>Processes</subject><subject>Product safety</subject><subject>Proteins</subject><issn>1542-166X</issn><issn>1939-1862</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNiksOwiAUAInRxPq5Ax6ApJRSi1uj0b0Ldw1WijXIQ3jGeHs18QBuZmYxA5JxJRTjdVUMPy3LgvGqOo7JJKVrnvNaqDIjq71HY6PG3lvqzZOiaS8eHNgX7T0CPTmAMw1Op5umXdQt9uD1FzMy6rRLZv7zlCy2m8N6x0KE-8MkbKIJEDE1XMmlLLhQ4p_nDTpXN90</recordid><startdate>20020901</startdate><enddate>20020901</enddate><creator>Curling, John</creator><general>MultiMedia Healthcare Inc</general><scope>3V.</scope><scope>7RV</scope><scope>7WY</scope><scope>7XB</scope><scope>883</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>KB0</scope><scope>L.-</scope><scope>LK8</scope><scope>M0F</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20020901</creationdate><title>Integrating new technology into blood plasma fractionation</title><author>Curling, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_1957521393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Biotechnology industry</topic><topic>Changes</topic><topic>Chromatography</topic><topic>FDA approval</topic><topic>Fractionation</topic><topic>Licenses</topic><topic>Manufacturing</topic><topic>Plasma</topic><topic>Polyethylene glycol</topic><topic>Processes</topic><topic>Product safety</topic><topic>Proteins</topic><toplevel>online_resources</toplevel><creatorcontrib>Curling, John</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Access via ABI/INFORM (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Trade & Industry (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ProQuest Biological Science Collection</collection><collection>ABI/INFORM Trade & Industry</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Biopharm</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Curling, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrating new technology into blood plasma fractionation</atitle><jtitle>Biopharm</jtitle><date>2002-09-01</date><risdate>2002</risdate><volume>15</volume><issue>9</issue><spage>16</spage><pages>16-</pages><issn>1542-166X</issn><eissn>1939-1862</eissn><abstract>Immune serum globulin is in high demand, and that demand will only increase. Yet despite product shortages, the complexities involved in creating new manufacturing processes discourage change. The benefits--increased yield, reduced costs, new technologies and faster throughput--now make identifying the best place in the processing stream to make manufacturing changes a rewarding endeavor.</abstract><cop>Cleveland</cop><pub>MultiMedia Healthcare Inc</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1542-166X |
| ispartof | Biopharm, 2002-09, Vol.15 (9), p.16 |
| issn | 1542-166X 1939-1862 |
| language | eng |
| recordid | cdi_proquest_reports_195752139 |
| source | EZB-FREE-00999 freely available EZB journals |
| subjects | Biotechnology industry Changes Chromatography FDA approval Fractionation Licenses Manufacturing Plasma Polyethylene glycol Processes Product safety Proteins |
| title | Integrating new technology into blood plasma fractionation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T00%3A52%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrating%20new%20technology%20into%20blood%20plasma%20fractionation&rft.jtitle=Biopharm&rft.au=Curling,%20John&rft.date=2002-09-01&rft.volume=15&rft.issue=9&rft.spage=16&rft.pages=16-&rft.issn=1542-166X&rft.eissn=1939-1862&rft_id=info:doi/&rft_dat=%3Cproquest%3E187559411%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195752139&rft_id=info:pmid/&rfr_iscdi=true |